{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:01:26Z","timestamp":1790308886789,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["2024qnGzn03"],"award-info":[{"award-number":["2024qnGzn03"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYFY-GQ65"],"award-info":[{"award-number":["CYFY-GQ65"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYFY2018GQ17"],"award-info":[{"award-number":["CYFY2018GQ17"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52402337"],"award-info":[{"award-number":["52402337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012551","name":"Sichuan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024NSFSC1519"],"award-info":[{"award-number":["2024NSFSC1519"]}],"id":[{"id":"10.13039\/100012551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.biomaterials.2026.124596","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:55:20Z","timestamp":1788155720000},"page":"124596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A ferroptosis nanoplatform for overcoming radioresistance in KRAS-mutant colorectal cancer"],"prefix":"10.1016","volume":"337","author":[{"given":"Luqian","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6868-1108","authenticated-orcid":false,"given":"Maoru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124596_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biomaterials.2026.124596_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/cells13030245","article-title":"Update on targeted therapy and immunotherapy for metastatic colorectal cancer","volume":"13","author":"Underwood","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124596_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-024-02216-3","article-title":"Targeting KRAS: from metabolic regulation to cancer treatment","volume":"24","author":"Shi","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124596_bib4","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1245\/s10434-025-17804-w","article-title":"The impact of RAS\/BRAF mutation on pathological complete response after total neoadjuvant therapy in rectal cancer","volume":"32","author":"Aboelmaaty","year":"2025","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jmoldx.2024.11.007","article-title":"Investigating the pathogenicity of uncommon KRAS mutations and their association with clinicopathologic characteristics in patients with colorectal cancer","volume":"27","author":"Adorisio","year":"2025","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.biomaterials.2026.124596_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1105180","article-title":"Radioimmunotherapy in colorectal cancer treatment: present and future","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216858","article-title":"Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer","volume":"591","author":"Jin","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124596_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232101","article-title":"Radiotherapy and immunology","volume":"221","author":"Wang","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124596_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111602","article-title":"Advances in nanoparticle-based radiotherapy for cancer treatment","volume":"28","author":"He","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.biomaterials.2026.124596_bib10","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1093\/nar\/gkab871","article-title":"Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair","volume":"49","author":"Yang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biomaterials.2026.124596_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-024-02218-1","article-title":"The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy","volume":"24","author":"Ma","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124596_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.7150\/ijms.107038","article-title":"NADPH oxidase activator 1 (NOXA1) suppresses ferroptosis and radiosensitization in colorectal cancer","volume":"22","author":"Jiang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biomaterials.2026.124596_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2025.01.026","article-title":"SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells","volume":"77","author":"Mao","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.biomaterials.2026.124596_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12967-026-07715-z","article-title":"Long noncoding RNA PCAT7 confers radioresistance of esophageal squamous cell carcinoma by promoting GCLM-mediated anti-ferroptosis","volume":"24","author":"Hao","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124596_bib15","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2026.124596_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41418-024-01427-x","article-title":"Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer","volume":"32","author":"Zhao","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biomaterials.2026.124596_bib17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41416-023-02149-6","article-title":"Ferroptosis in colorectal cancer: a future target?","volume":"128","author":"Yan","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124596_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trecan.2024.11.009","article-title":"KRAS inhibitors: resistance drivers and combinatorial strategies","volume":"11","author":"Isermann","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biomaterials.2026.124596_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/cancers17030428","article-title":"The role of KRAS mutations in colorectal cancer: biological insights, clinical implications, and future therapeutic perspectives","volume":"17","author":"Takeda","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2026.124596_bib20","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41467-026-70861-x","article-title":"Spatial heterogeneity of MDSCs mediated by ANXA1-FPRs signaling drives immune suppression in OSCC progression","volume":"17","author":"Li","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124596_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300517","article-title":"Ferroptosis-enhanced immunotherapy with an injectable Dextran-Chitosan hydrogel for the treatment of malignant ascites in hepatocellular carcinoma","volume":"10","author":"Meng","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124596_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.170958","article-title":"Bio-derived nanoplatforms: emerging strategies for inflammatory bowel disease therapy","volume":"526","author":"Qin","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2026.124596_bib23","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","article-title":"xCT: a critical molecule that links cancer metabolism to Redox signaling","volume":"28","author":"Liu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2026.124596_bib24","article-title":"A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging","volume":"19","author":"Guan","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124596_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500406","article-title":"Dopant-regulated piezocatalysts evoke sonopiezoelectric and enzymatic PANoptosis for synergistic cancer therapy","volume":"12","author":"Zhong","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124596_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101997","article-title":"Ultra-small radiosensitizers deliver epigenetic drugs to induce pyroptosis and boost triple-negative breast cancer radiotherapy","volume":"52","author":"Liu","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124596_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2018.07.677","article-title":"Hafnium oxide nanoparticles activated by radiation therapy for the treatment of solid tumors","volume":"102","author":"Le Tourneau","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.biomaterials.2026.124596_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202413518","article-title":"Nitric oxide-releasing nanoscale metal-organic layer overcomes hypoxia and reactive oxygen species diffusion barriers to enhance cancer radiotherapy","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124596_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.biomaterials.2026.124596_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","article-title":"Prognostic genome and transcriptome signatures in colorectal cancers","volume":"633","author":"Nunes","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124596_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36550","article-title":"Mutation patterns in colorectal cancer and their relationship with prognosis","volume":"10","author":"Su","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.biomaterials.2026.124596_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51981-5","article-title":"Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients","volume":"9","author":"Bray","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124596_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012886","article-title":"Tumor immune microenvironment facilitates resistance to KRAS G12C inhibitor sotorasib by altered PD-L1 expression","volume":"14","author":"Liu","year":"2026","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124596_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104497","article-title":"Colorectal cancer with BRAF V600E mutation: trends in immune checkpoint inhibitor treatment","volume":"204","author":"Liu","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib36","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3390\/ijms26051988","article-title":"Mechanisms and strategies to overcome drug resistance in colorectal cancer","volume":"26","author":"Haynes","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124596_bib37","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/ueg2.70086","article-title":"Pan-ERBB inhibitors synergize with KRAS inhibitors in rectal cancer","volume":"13","author":"Buchloh","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.biomaterials.2026.124596_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41698-022-00334-z","article-title":"Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors","volume":"6","author":"Lee","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib39","first-page":"1","article-title":"Comprehensive analysis of KRAS aberrations in pan-cancer, with a focus on prognostic and therapeutic implications","volume":"17","author":"Jaeyun","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib40","article-title":"Tumor regression pattern may impact the prognosis of rectal cancer patients with tumor regression grade 1 after neoadjuvant chemoradiotherapy","volume":"12","author":"Tang","year":"2024","journal-title":"Gastroenterology Report"},{"key":"10.1016\/j.biomaterials.2026.124596_bib41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12094-024-03592-4","article-title":"Poor therapeutic outcomes in KRAS-mutant non-small cell lung cancer due to chemoresistance conferred by SLC7A11","volume":"27","author":"Zhang","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144742","article-title":"CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein","volume":"317","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2026.124596_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101250","article-title":"Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis","volume":"81","author":"He","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.biomaterials.2026.124596_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"7","author":"Tang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124596_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/antiox15020237","article-title":"Inducing ferroptosis: sensitization strategy for radiotherapy and its application","volume":"15","author":"Chen","year":"2026","journal-title":"Antioxidants"},{"key":"10.1016\/j.biomaterials.2026.124596_bib46","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1021\/acsami.2c20467","article-title":"Mussel-inspired tantalum nanocomposite hydrogels for in situ oral cancer treatment","volume":"15","author":"Zhao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2026.124596_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.131725","article-title":"Fullerenol@nano-montmorillonite nanocomposite as an efficient radioprotective agent for ameliorating radioactive duodenal injury","volume":"427","author":"Wang","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2026.124596_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.178601","article-title":"Intestine-targeted mucoadhesive hydrogel microspheres for alleviating intestinal ischemia-reperfusion injury and intestinal flora disorder","volume":"545","author":"Qin","year":"2026","journal-title":"Chem. Eng. J."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:57:13Z","timestamp":1790308633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":48,"alternative-id":["S0142961226006204"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124596","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A ferroptosis nanoplatform for overcoming radioresistance in KRAS-mutant colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124596"}}